Nathan J Dowden insider trades: Entrada Therapeutics (TRDA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nathan reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | TRDA | ↓ Sell | 15,000 | $15.33 | $230K | Direct | May 4, 2026 (0d) |
| Sep 26, 2024 | TRDA | ↓ Sell | 847 | $16.00 | $14K | Direct | Sep 30, 2024 (4d) |
| Sep 9, 2024 | TRDA | ↓ Sell | 2,303 | $15.09 | $35K | Direct | Sep 10, 2024 (1d) |
| Aug 16, 2024 | TRDA | ↓ Sell | 27,097 | $16.27 | $441K | Direct | Aug 20, 2024 (4d) |
| Mar 6, 2024 | TRDA | ↓ Sell | 1,826 | $12.32 | $22K | Direct | Mar 8, 2024 (2d) |
| Sep 6, 2023 | TRDA | ↓ Sell | 972 | $13.47 | $13K | Direct | Sep 6, 2023 (0d) |
| Jul 11, 2023 | TRDA | ↓ Sell | 7,097 | $18.03 | $128K | Direct | Jul 12, 2023 (1d) |
| Jun 22, 2023 | TRDA | ↓ Sell | 15,982 | $15.42 | $246K | Direct | Jun 22, 2023 (0d) |
| Oct 31, 2022 | TRDA | ↓ Sell | 2,100 | $24.05 | $50K | Direct | Nov 2, 2022 (2d) |
| Oct 25, 2022 | TRDA | ↓ Sell | 9,348 | $20.77 | $194K | Direct | Oct 27, 2022 (2d) |
| Oct 24, 2022 | TRDA | ↓ Sell | 6,080 | $18.66 | $113K | Direct | Oct 24, 2022 (0d) |
| Sep 26, 2022 | TRDA | ↓ Sell | 1,544 | $15.45 | $24K | Direct | Sep 28, 2022 (2d) |
| Sep 23, 2022 | TRDA | ↓ Sell | 4,293 | $15.11 | $65K | Direct | Sep 23, 2022 (0d) |
| Sep 15, 2022 | TRDA | ↓ Sell | 100 | $15.01 | $2K | Direct | Sep 19, 2022 (4d) |
| Sep 9, 2022 | TRDA | ↓ Sell | 1,777 | $15.11 | $27K | Direct | Sep 12, 2022 (3d) |
| Jun 27, 2022 | TRDA | ↓ Sell | 7,714 | $13.00 | $100K | Direct | Jun 29, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TRDA insiders
Open-market trades in the last 12 months
About Nathan J Dowden's insider trades
Nathan J Dowden is President & COO at Entrada Therapeutics (TRDA). Since Jun 27, 2022, Nathan has reported no open-market purchases and 16 sales worth $1.7M on SEC Form 4. In the last 12 months: 1 sale ($230K).
Their filings also include grants and awards (9 filings), shares withheld for taxes (8 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TRDA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.